bio-technology general corp. received tenders for 97.9 % of its 7.5_% convertible senior_subordinated notes_due april 15 , 1997 , and 96 % of its 11_% convertible senior_subordinated debentures_due march 1 , 2006 . in exchange offers that expired friday , holders of each $_1,000 of notes will_receive $_250 face_amount of series a 7.5_% senior_secured convertible_notes due jan. 15 , 1995 , and 200 common_shares . for each $_1,000 face_amount of debentures , holders received $_250 of series_b 11_% senior_secured convertible_notes due_oct. 15 , 1998 , and 200 common_shares . bio-technology , a new_york maker of genetically_engineered products for human and animal health_care , said_0 it made the exchange offer to reduce_its interest_payments .